MedicPen AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
MedicPen publ AB Announces Directed Share Issue
MedicPen publ AB announced that the Company is carrying out a directed share issue of approximately 8.5 million shares and a warrant (TO2) per share, raising approximately SEK 5.1 million in proceeds before issue costs. Through the issue the Company's share capital increases by 21%. Additionally, the issue of TO2 may potentially result in proceeds of approximately SEK 4.7 million. Subscription price has been set at SEK 0.60 per share. Per each share a TO2 will be assigned. Two TO2s will entitle the holder to subscribe for one new share in MedicPen. The warrants are to be exercised before December 6, 2013. Subscription price will be SEK 1.1 per share. The issue is directed towards Capensor Capital AB and a small number of private investors.
Latest Key Developments in Medical
- YOOX SpA enters FTSE MIB of Borsa Italiana on Dec. 23 and DiaSorin SpA and Parmalat exit-Reuters
- Landauer Inc gives FY 2014 guidance; earnings guidance below analysts' estimates
- Baxter International Inc files for pediatric indication of RIXUBIS
- Covidien PLC announces definitive agreement to acquire Given Imaging Ltd
- Share this
- Digg this